8 September 2020
Sidley Advises GlaxoSmithKline plc on the Refinancing of Its Core Revolving Credit Facilities Linked to SONIA and SOFR Risk-Free Rates
Advising firms
Deal team
8 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| David Howe Lead | Sidley | Partner | Capital Markets | London |
| Benedetta Pacifico | Sidley | Senior associate | Capital Markets | London |
| David Kucharski | Sidley | Associate | Capital Markets | London |
| Alistair Gunn | Sidley | Trainee | Capital Markets | London |
| Oliver Currall | Sidley | Partner | Tax | London |
| Oliver Rosshandler | Sidley | Associate | Tax | London |
| Greg Brown | A&O Shearman | Partner | Not stated | London |
| Dominique Crowley | A&O Shearman | Associate | Not stated | London |
5 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 2.50bn (US$2.5 billion)
- What the figure measures
- Facility amount
- Client
- GlaxoSmithKline plcBorrower
- Counterparties
- HSBC Bank plc (Lenders)